A phase I study to evaluate the safety of ascending doses of FPA144 in combination with chemotherapy

Trial Profile

A phase I study to evaluate the safety of ascending doses of FPA144 in combination with chemotherapy

Planning
Phase of Trial: Phase I

Latest Information Update: 15 Aug 2017

At a glance

  • Drugs FPA 144 (Primary)
  • Indications Gastric cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Aug 2017 New trial record
    • 08 Aug 2017 According to a Five Prime Therapeutics media release, This safety trial will support the start of the global Phase 3 clinical trial.
    • 08 Aug 2017 According to a Five Prime Therapeutics media release, the company plans to begin dosing in this trial by the end of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top